Trial Radar KI | ||
|---|---|---|
Die klinische Studie NCT07364227 für Adhesive Capsulitis of the Shoulder, Intra Articular Injection ist noch nicht rekrutierend. In der Kartenansicht des Klinische Studien Radar und den KI-Entdeckungstools finden Sie alle Details. Oder stellen Sie hier Ihre Fragen. | ||
Eine Studie entspricht den Filterkriterien
Kartenansicht
Anterior vs Posterior vs Combined Intra-Articular Injections for Adhesive Capsulitis 30 Randomisiert
Die Details der klinischen Studie sind hauptsächlich auf Englisch verfügbar. Trial Radar KI kann jedoch helfen! Klicken Sie einfach auf 'Studie erklären', um die Informationen zur Studie in der ausgewählten Sprache anzuzeigen und zu besprechen.
Die klinische Studie NCT07364227 ist eine interventionsstudie zur Untersuchung von Adhesive Capsulitis of the Shoulder, Intra Articular Injection und hat den Status noch nicht rekrutierend. Der Start ist für 1. Januar 2026 geplant, bis 30 Teilnehmer aufgenommen werden. Durchgeführt von Aslinur Keles Ercisli, MD, PhD wird der Abschluss für 1. Juli 2026 erwartet. Die Daten von ClinicalTrials.gov wurden zuletzt am 23. Januar 2026 aktualisiert.
Kurzbeschreibung
This randomized controlled clinical trial aims to compare the efficacy of three different intra-articular injection approaches (anterior, posterior, and combined anterior-posterior) in patients with adhesive capsulitis of the shoulder. Thirty participants will be randomly assigned to one of three groups and treated with a standardized injection solution consisting of corticosteroid, lidocaine, and saline. Clinical ou...Mehr anzeigen
Ausführliche Beschreibung
Adhesive capsulitis (frozen shoulder) is a disabling condition characterized by progressive pain and stiffness of the glenohumeral joint. Intra-articular corticosteroid injections are frequently used to reduce pain and improve mobility; however, the optimal injection approach remains controversial.
This single-center randomized controlled trial will investigate three different approaches: posterior, anterior, and co...
Mehr anzeigenOffizieller Titel
Comparison of Anterior, Posterior, and Combined Intra-Articular Injection Techniques in Patients With Adhesive Capsulitis
Erkrankungen
Adhesive Capsulitis of the ShoulderIntra Articular InjectionWeitere Studien-IDs
- ADC2025
NCT-Nummer
Studienbeginn (tatsächlich)
2026-01
Zuletzt aktualisiert
2026-01-23
Studienende (vorauss.)
2026-07
Geplante Rekrutierung
30
Studientyp
Interventionsstudie
PHASE
Nicht zutreffend
Status
Noch nicht rekrutierend
Stichwörter
Adhesive Capsulitis of the Shoulder
Intra-articular Injection
Frozen Shoulder
Ultrasound
Shoulder Pain
Intra-articular Injection
Frozen Shoulder
Ultrasound
Shoulder Pain
Primäres Ziel
Behandlung
Zuteilungsmethode
Randomisiert
Interventionsmodell
Parallel
Verblindung
Keine (offene Studie)
Studienarme/Interventionen
| Teilnehmergruppe/Studienarm | Intervention/Behandlung |
|---|---|
ExperimentellArm A: Posterior Injection Single intra-articular injection with corticosteroid + lidocaine + saline via the posterior glenohumeral approach. | Intervention Name: Posterior Intra-articular Injection A single intra-articular injection consisting of 1 cc corticosteroid, 4 cc 2% lidocaine, and 5 cc saline (total 10 cc) administered via the posterior glenohumeral approach. |
ExperimentellArm B - Anterior Injection Same injection solution administered via the anterior (rotator interval) approach. | Anterior Intra-articular Injection A single intra-articular injection consisting of 1 cc corticosteroid, 4 cc 2% lidocaine, and 5 cc saline (total 10 cc) administered via the anterior (rotator interval) approach. |
ExperimentellArm C - Combined Anterior + Posterior Injection Same injection solution administered using both anterior and posterior approaches. | Combined Anterior + Posterior Intra-articular Injection A single intra-articular injection consisting of 1 cc corticosteroid, 4 cc 2% lidocaine, and 5 cc saline (total 10 cc) administered using both anterior and posterior approaches during the same procedure. |
Hauptergebnismessungen
Nebenergebnismessungen
| Ergebnismessung | Beschreibung der Messung | Zeitrahmen |
|---|---|---|
Change in Shoulder Range of Motion (ROM) | Change in active and passive shoulder joint range of motion (flexion, extension, abduction, external rotation, internal rotation) measured with a goniometer. | Baseline, immediately post-injection, week 3, week 6, week 12 |
| Ergebnismessung | Beschreibung der Messung | Zeitrahmen |
|---|---|---|
Change in Pain Intensity (NRS) | Number Rating Scale (0-10) for pain at rest, during activity, and at night. | Baseline, immediately post-injection, week 3, week 6, week 12 |
Subjective Shoulder Value (SSV) | Patient's self-reported percentage of normal shoulder function (0-100%). | Baseline, immediately post-injection, week 3, week 6, week 12 |
Shoulder Pain and Disability Index (SPADI) | Questionnaire assessing pain and disability (0-100 score, higher scores = worse function). | Baseline, week 3, week 6, week 12 |
Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) | Questionnaire measuring upper limb disability and symptoms (0-100 score, higher = worse). | Baseline, week 3, week 6, week 12 |
American Shoulder and Elbow Surgeons (ASES) Score | Composite score including pain and function (0-100, higher = better). | Baseline, week 3, week 6, week 12 |
Constant-Murley Shoulder Score | Clinical score combining pain, activities of daily living, strength, and ROM (0-100). | Baseline, week 3, week 6, week 12 |
Scratch Test Score | Functional test measuring the patient's ability to reach behind the back. | Baseline, immediately post-injection, week 3, week 6, week 12 |
Axillary Capsule Thickness (Ultrasound) | Ultrasound measurement of axillary recess capsule thickness on the affected shoulder. | Baseline, immediately post-injection (only). |
Teilnahme-Assistent
Eignungskriterien
Zugelassene Altersgruppen
Erwachsene, Ältere Erwachsene
Mindestalter
18 Years
Zugelassene Geschlechter
Alle
Aslinur Keles Ercisli, MD, PhDVerantwortliche Partei
Aslinur Keles Ercisli, MD, PhD, Prüfsponsor, Principal investigator, Fatih Sultan Mehmet Training and Research Hospital
Zentrale Studienkontakte
Kontakt: Aslinur K Keles, MD., PhD, +905395010707, [email protected]
Kontakt: esra K giray, Assoc Prof, +90 555 813 43 94, [email protected]
Keine Standortdaten vorhanden